The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

In Brief

Hesse named president, CEO of CTCA Philadelphia center

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

NANCY HESSE was named president and CEO of the Cancer Treatment Centers of America Eastern Regional Medical Center (Eastern) in Philadelphia.

Hesse has served as interim president and CEO since February 2016, and before that as chief nursing executive for CTCA and chief nursing officer at Eastern.

Hesse joined CTCA in 2014 after a long tenure at Abington Memorial Hospital. She began her career as a staff nurse in the Emergency Trauma Center and advanced to become the Director of Emergency Trauma and then Chief Nursing Officer for Abington – Lansdale Hospital.

CTCA is a national network of five cancer hospitals.

Table of Contents

YOU MAY BE INTERESTED IN

Regulatory News

FDA grants Replimune’s RP1 an accelerated approval on third submission after 10:3 vote from advisory committee
Amid political outcry, advisors accept weak data and give sponsor a chance to complete phase III trial

FDA has granted an accelerated approval to RP1 (vusolimogene oderparepvec) following the agency’s Cellular, Tissue, and Gene Therapies Advisory Committee’s 10:3 vote in support of the biologic in combination with nivolumab for the treatment of advanced melanoma in patients who have progressed on prior anti-PD-1 therapy.
By Jacquelyn Cobb and Paul Goldberg
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account